en
/
sv
About Elicera
Elicera in brief
Board
Management
Elicera's history
Immuno-oncology
What is immuno-oncology?
Oncolytic virus
CAR T-cell therapy
Technology
Strengths
ELC-001
ELC-100
ELC-201
ELC-301
ELC-401
Patents
Pipeline
Pipeline
Clinical trials
Investors
Press Releases
Articles of Association
General Meeting
Board
Management
the Share
Financial Reports
Financial Calendar
Events
News
News
Press Releases
Planned IPO
Events
Contact
Financial Calendar
Year-End Report: 2021-02-18
Q1-report: 2021-04-14
Annual General Meeting: 2021-04-26
Q2-report: 2021-08-19
Q3-report: 2021-11-17
Year-End Report: 2022-02-16